Intriguingly, although recognized originally as a target of chemopreventive compounds that help prevent cancer and other diseases, accumulating evidence suggests that Nrf2 has a contradictory role in cancers, and overexpression of Nrf2 can promote cancer progression, metastasis, and resistance to anticancer drugs [24]. This evidence concerns the gene NFE2L2 and cancer.